NHS England launches two clinical trials investigating puberty blockers' effects on young people with gender incongruence following the Cass review's findings of insufficient evidence. Learn about the studies' structure and ethical debates.
UK regulators approve landmark clinical trials for puberty-blocking drugs in children. The study aims to provide crucial evidence on risks and benefits for young people with gender incongruence.
New Zealand halts new puberty blocker prescriptions for gender-diverse youth, citing evidence concerns. Critics warn of devastating mental health impacts. Learn more about the policy change.
After successfully overturning Queensland's controversial puberty blocker ban, activist Bridget Gilly now faces renewed legislation. Discover why she's not backing down from this critical healthcare fight.